In Vitro & In Vivo Diagnostic Substances Industry - SEC Form 4 Insider Trading Screener

Manufacturing Sector - Chemicals - In Vitro & In Vivo Diagnostic Substances
General
Tickers
Insider
Sh Price $
Lqdty M$
Date
Filing Date
  
Trade Date
  
Filing Delay
N Days Ago
Transaction Filing
P - Purchase
S - Sale
A - Grant
D - Sale to Iss
G - Gift
F - Tax
M - Option Ex
X - Option Ex
C - Cnv Deriv
W - Inherited
No deriv Multiple Days
Traded K$
Own Chg %
Industry
Insider Title   Officer
    COB
    CEO
    Pres
    COO
    CFO
    GC
    VP
  Director
  10% Own
  Other
Group by
Sort by
Max Results
Page
clear
Real-time CSV, Options, Alerts
100 results - Yahoo - Google - Finviz - Stockcharts - Tradingview - Stocktwits - SEC
TCcnt1d1w1m6m

X

Filing Date

Trade Date

Ticker

Company

Insider Name

Insider Title

Trade Type 

Price

Qty

Owned

ΔOwn

Value

1d

1w

1m

6m

2019-07-18
NEOGNeogen CorpHerbert James LDirS - Sale$65.03-56,229565,225-9%-$3,656,673
M
2019-07-15
NEOGNeogen CorpHerbert James LDirS - Sale$63.97-10,000621,484-2%-$639,668
2019-07-10
LNTHLantheus Holdings, Inc.Duffy Michael PSVP, GCS - Sale$28.14-8,819144,494-6%-$248,167
2019-07-10
LNTHLantheus Holdings, Inc.Markison Brian ADirS - Sale$28.07-4,91827,549-15%-$138,048
2019-07-10
NYMXNymox Pharmaceutical CorpRobinson James GeorgeDirP - Purchase$1.73+7,0003,510,5500%+$12,104
2019-07-08
NEOGNeogen CorpHerbert James LDirS - Sale$60.70-5,000631,484-1%-$303,510
D
2019-07-08
LNTHLantheus Holdings, Inc.Orlandi CesareChief Medical OfficerS - Sale+OE$28.17-35,58668,483-34%-$1,002,615
2019-07-09
NYMXNymox Pharmaceutical CorpRobinson James GeorgeDirP - Purchase$1.63+7,0003,503,5500%+$11,400
2019-07-05
NYMXNymox Pharmaceutical CorpRobinson James GeorgeDirP - Purchase$1.45+9,0003,496,5500%+$13,049
2019-07-03
LNTHLantheus Holdings, Inc.Markison Brian ADirS - Sale$28.41-5,00032,467-13%-$142,050
2019-07-03
NYMXNymox Pharmaceutical CorpRobinson James GeorgeDirP - Purchase$1.54+8,0003,487,5500%+$12,354
2019-07-02
OCXOncocyte CorpBroadwood Partners, L.P.10%P - Purchase$2.00+1,000,00018,199,679+6%+$2,000,000
D
2019-06-28
VRMLVermillion, Inc.Schuler Henri George10%P - Purchase$0.80+4,750,00013,764,495+53%+$3,800,000
2019-06-28
VRMLVermillion, Inc.Schuler Jack W10%P - Purchase$0.80+5,000,00022,378,242+29%+$4,000,000
2019-07-01
NEOGNeogen CorpHerbert James LDirS - Sale$61.52-5,000636,484-1%-$307,600
2019-07-01
NYMXNymox Pharmaceutical CorpRobinson James GeorgeDirP - Purchase$1.37+9,0003,479,5500%+$12,305
2019-06-28
VRMLVermillion, Inc.Palmieri Valerie BarberPres, CEOP - Purchase$0.80+37,500215,563+21%+$30,000
M
2019-06-28
NYMXNymox Pharmaceutical CorpRobinson James GeorgeDirP - Purchase$15.16+10,0003,470,5500%+$151,568
DM
2019-06-26
QDELQuidel Corp /de/Bryant Douglas CPres, CEOS - Sale+OE$57.59-28,711301,442-9%-$1,653,481
M
2019-06-26
IMMUImmunomedics IncAvoro Capital Advisors LLCSee Remarks, 10%P - Purchase$13.55+1,000,00041,413,516+2%+$13,548,000
2019-06-26
LNTHLantheus Holdings, Inc.Markison Brian ADirS - Sale$27.67-5,00037,467-12%-$138,361
2019-06-27
NYMXNymox Pharmaceutical CorpRobinson James GeorgeDirP - Purchase$1.56+9,0003,460,5500%+$14,023
A
2019-06-18
LNTHLantheus Holdings, Inc.Bolla John J.Chief Operations OfficerS - Sale$27.58-2,24136,405-6%-$61,807
2019-06-26
NYMXNymox Pharmaceutical CorpRobinson James GeorgeDirP - Purchase$1.71+8,0003,451,5500%+$13,680
2019-06-25
NYMXNymox Pharmaceutical CorpRobinson James GeorgeDirP - Purchase$1.73+9,0003,443,5500%+$15,533
2019-06-24
NEOGNeogen CorpHerbert James LDirS - Sale$61.41-5,000641,484-1%-$307,040
2019-06-20
LNTHLantheus Holdings, Inc.Heino Mary AnnePres, CEOS - Sale$27.89-14,340623,422-2%-$399,935
2019-06-18
NAVBNavidea Biopharmaceuticals, Inc.Scott John K Jr.10%P - Purchase$0.75+4,000,0005,123,217+356%+$3,000,000
2019-06-19
LNTHLantheus Holdings, Inc.Markison Brian ADirS - Sale$27.40-5,00042,467-11%-$137,015
2019-06-20
NYMXNymox Pharmaceutical CorpRobinson James GeorgeDirP - Purchase$1.77+9,0003,434,5500%+$15,918
2019-06-20
IMMUImmunomedics IncBall BryanChief Quality OfficerP - Purchase$13.35+5,0005,000New+$66,750
D
2019-06-18
QDELQuidel Corp /de/Russell Edward KeithS.VP, N.A. Commercial OpsS - Sale+OE$57.16-13,0009,598-58%-$743,046
M
2019-06-18
LNTHLantheus Holdings, Inc.Bolla John J.Chief Operations OfficerS - Sale$27.56-1,74737,027-5%-$48,149
2019-06-19
NYMXNymox Pharmaceutical CorpRobinson James GeorgeDirP - Purchase$1.69+8,0003,425,5500%+$13,529
2019-06-18
NYMXNymox Pharmaceutical CorpRobinson James GeorgeDirP - Purchase$1.67+9,0003,417,5500%+$15,046
2019-06-17
NEOGNeogen CorpHerbert James LDirS - Sale$61.61-5,000646,484-1%-$308,060
2019-06-13
NYMXNymox Pharmaceutical CorpRobinson James GeorgeDirP - Purchase$1.42+8,0003,408,5500%+$11,344
D
2019-06-13
QTNTQuotient LtdHallsworth FrederickDirP - Purchase$8.70+3,15077,548+4%+$27,405
2019-06-12
NEOGNeogen CorpHerbert James LDirS - Sale$60.65-20,000651,484-3%-$1,213,078
2019-06-12
LNTHLantheus Holdings, Inc.Markison Brian ADirS - Sale$25.27-5,00047,467-10%-$126,365
2019-06-11
ACHVAchieve Life Sciences, Inc.Armistice Capital, LLC10%S - Sale$2.86-47,1821,593,188-3%-$134,821
2019-06-11
ACHVAchieve Life Sciences, Inc.Armistice Capital, LLC10%S - Sale$3.16-264,9631,687,552-14%-$837,467
2019-06-11
ACHVAchieve Life Sciences, Inc.Armistice Capital, LLC10%P - Purchase$3.80+12,8131,687,552+1%+$48,689
2019-06-11
VNRXVolitionrx LtdFaulkes Martin CharlesDirP - Purchase$3.11+79,2691,857,284+4%+$246,134
2019-06-10
VNRXVolitionrx LtdFaulkes Martin CharlesDirP - Purchase$3.02+70,7311,778,015+4%+$213,608
2019-06-11
NYMXNymox Pharmaceutical CorpRobinson James GeorgeDirP - Purchase$1.46+9,0003,400,5500%+$13,149
2019-06-10
NYMXNymox Pharmaceutical CorpRobinson James GeorgeDirP - Purchase$1.54+8,0003,391,5500%+$12,288
2019-06-07
LNTHLantheus Holdings, Inc.Leno Sam RDirS - Sale$25.33-3,95049,580-7%-$100,059
2019-06-05
LNTHLantheus Holdings, Inc.Markison Brian ADirS - Sale$24.60-5,00052,467-9%-$123,010
2019-06-05
NAVBNavidea Biopharmaceuticals, Inc.Latkin JedCEO, COO, CFOP - Purchase$1.26+1,00012,950+8%+$1,258
2019-06-06
NYMXNymox Pharmaceutical CorpRobinson James GeorgeDirP - Purchase$1.56+10,0003,383,5500%+$15,648
2019-06-05
NYMXNymox Pharmaceutical CorpRobinson James GeorgeDirP - Purchase$1.55+11,0003,373,5500%+$17,093
M
2019-06-03
IMMUImmunomedics IncAvoro Capital Advisors LLCSee Remarks, 10%P - Purchase$12.21+1,535,53939,253,849+4%+$18,743,220
2019-06-03
VRMLVermillion, Inc.Schreiber DavidDirS - Sale$1.10-10,000164,905-6%-$11,000
2019-05-31
IDXXIdexx Laboratories Inc /deTwigge GiovaniCORPORATE VPS - Sale$250.14-2,60012,595-17%-$650,363
2019-06-03
NYMXNymox Pharmaceutical CorpRobinson James GeorgeDirP - Purchase$1.62+9,0003,362,5500%+$14,598
2019-05-31
NYMXNymox Pharmaceutical CorpRobinson James GeorgeDirP - Purchase$1.59+10,0003,353,5500%+$15,925
2019-05-29
LNTHLantheus Holdings, Inc.Markison Brian ADirS - Sale$24.29-5,00057,467-8%-$121,454
D
2019-05-29
QTNTQuotient LtdFarrell EdwardPresS - Sale+OE$9.95-11,00014,566-43%-$109,450
D
2019-05-29
QTNTQuotient LtdStackawitz JeremyPresS - Sale+OE$9.93-21,495131,939-14%-$213,445
2019-05-30
NYMXNymox Pharmaceutical CorpRobinson James GeorgeDirP - Purchase$1.76+8,5003,343,5500%+$14,967
2019-05-28
NYMXNymox Pharmaceutical CorpRobinson James GeorgeDirP - Purchase$1.68+9,0003,335,0500%+$15,098
2019-05-24
NYMXNymox Pharmaceutical CorpRobinson James GeorgeDirP - Purchase$1.59+8,0003,326,0500%+$12,750
2019-05-23
NYMXNymox Pharmaceutical CorpRobinson James GeorgeDirP - Purchase$1.55+7,5003,318,0500%+$11,657
2019-05-23
ACHVAchieve Life Sciences, Inc.Stewart Richard AlistairCOB, CEOP - Purchase$3.61+17,500237,357+8%+$63,093
2019-05-22
LNTHLantheus Holdings, Inc.Markison Brian ADirS - Sale$24.73-5,00062,467-7%-$123,628
2019-05-22
VIVOMeridian Bioscience IncRice John McCune Jr.DirP - Purchase$11.26+2,0005,981+50%+$22,516
2019-05-20
QDELQuidel Corp /de/Slacik Charles PDirS - Sale$55.19-1,0008,703-10%-$55,190
M
2019-05-13
NEOGNeogen CorpHerbert James LDirS - Sale$59.05-15,000983,857-2%-$885,711
2019-05-20
LNTHLantheus Holdings, Inc.Heino Mary AnnePres, CEOS - Sale$23.89-16,827637,762-3%-$401,940
2019-05-17
NAVBNavidea Biopharmaceuticals, Inc.Rouan Sarah KathrynDirP - Purchase$1.46+3,3508,350+67%+$4,904
2019-05-16
VIVOMeridian Bioscience IncAnderson James M.DirP - Purchase$11.37+5,00016,981+42%+$56,855
2019-05-15
LNTHLantheus Holdings, Inc.Markison Brian ADirS - Sale$24.75-5,00067,467-7%-$123,755
M
2019-05-16
NAVBNavidea Biopharmaceuticals, Inc.Latkin JedCEO, COO, CFOP - Purchase$1.46+2,50011,950+26%+$3,643
2019-05-17
VRMLVermillion, Inc.Beechey Robert HarryCFOP - Purchase$1.26+5,000205,000+3%+$6,292
D
2019-05-13
IDXXIdexx Laboratories Inc /deHenderson Rebecca MDirS - Sale+OE$241.57-8,79018,696-32%-$2,123,422
M
2019-05-13
IMMUImmunomedics IncAvoro Capital Advisors LLCSee RemarksP - Purchase$15.11+750,00036,682,771+2%+$11,328,750
2019-05-13
NAVBNavidea Biopharmaceuticals, Inc.Bruck ClaudineDirP - Purchase$1.90+2,5507,550+51%+$4,855
M
2019-05-13
NAVBNavidea Biopharmaceuticals, Inc.Latkin JedCEO, COO, CFOP - Purchase$1.80+5,4009,450+133%+$9,721
D
2019-05-10
QDELQuidel Corp /de/Buechler Kenneth FDirS - Sale+OE$60.58-2,00247,769-4%-$121,286
2019-05-10
IDXXIdexx Laboratories Inc /deLane MichaelCorporate VPS - Sale$245.41-1,8124,544-29%-$444,683
D
2019-05-10
NEOGNeogen CorpBoehm William TDirS - Sale+OE$60.84-4,00010,479-28%-$243,380
2019-05-13
VIVOMeridian Bioscience IncPhillips DavidDirP - Purchase$11.40+5,00044,107+13%+$57,015
2019-05-08
LNTHLantheus Holdings, Inc.Markison Brian ADirS - Sale$25.22-5,00072,467-6%-$126,116
D
2019-05-08
QTNTQuotient LtdFarrell EdwardPresS - Sale+OE$8.67-22,5002,133-91%-$195,075
D
2019-05-08
QTNTQuotient LtdStackawitz JeremyPresS - Sale+OE$8.67-22,500131,939-15%-$195,075
2019-05-08
VIVOMeridian Bioscience IncKenny John P.CEOP - Purchase$11.49+20,00083,000+32%+$229,744
D
2019-05-06
NEOGNeogen CorpMorrical Terri AVPS - Sale+OE$61.69-7,60037,575-17%-$468,853
2019-05-06
NEOGNeogen CorpHerbert James LDirS - Sale$60.79-5,000676,484-1%-$303,926
2019-05-06
IDXXIdexx Laboratories Inc /deTwigge GiovaniCORPORATE VPS - Sale$250.00-2,01515,195-12%-$503,750
D
2019-05-03
IDXXIdexx Laboratories Inc /deMcKeon Brian PEVP, CFOS - Sale+OE$247.87-7,50447,528-14%-$1,859,999
D
2019-05-03
IDXXIdexx Laboratories Inc /deAyers Jonathan WCOB, Pres, CEOS - Sale+OE$249.03-28,0001,163,916-2%-$6,972,700
2019-05-01
OXFDOxford Immunotec Global PlcSandberg Richard ADirS - Sale$16.05-3,0003,000-50%-$48,155
M
2019-04-30
LNTHLantheus Holdings, Inc.Markison Brian ADirS - Sale$24.11-10,00077,467-11%-$241,056
D
2019-05-01
NEOGNeogen CorpQuinlan Steven J.VP, CFOS - Sale+OE$60.13-6,90213,470-34%-$415,016
2019-04-29
LNTHLantheus Holdings, Inc.Duffy Michael PSee RemarksS - Sale$24.84-6,908153,313-4%-$171,615
2019-04-29
LNTHLantheus Holdings, Inc.Orlandi CesareChief Medical OfficerS - Sale$24.85-11,25068,483-14%-$279,617
2019-05-01
NEOGNeogen CorpParnell Jack CDirS - Sale$60.58-4,00010,439-28%-$242,320
2019-04-29
NEOGNeogen CorpHerbert James LDirS - Sale$60.01-25,000681,484-4%-$1,500,155
2019-04-29
NEOGNeogen CorpParnell Jack CDirS - Sale$60.26-5,00014,439-26%-$301,300
AAmended filing
DDerivative transaction in filing (usually option exercise)
EError detected in filing
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top